Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases

被引:105
|
作者
Wu, Xinyu [1 ,2 ]
Tian, Jie [2 ]
Wang, Shengjun [1 ,2 ]
机构
[1] Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China
[2] Jiangsu Univ, Sch Med, Dept Immunol, Jiangsu Key Lab Lab Med, Zhenjiang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Th17; cells; IL-10; inflammation; immunosuppression; autoimmune diseases; REGULATORY T-CELLS; NONOBESE DIABETIC MICE; T(H)17 CELLS; C-MAF; TRANSCRIPTION FACTOR; TGF-BETA; IL-17; INTERLEUKIN-17; EXPRESSION; INDUCTION;
D O I
10.3389/fimmu.2018.01112
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Th17 cells are generally considered to be positive regulators of immune responses because they produce pro-inflammatory cytokines, including IL-17A, IL-17F, and IL-22. Cytokine production not only promotes accumulation of immune cells, such as macrophages, neutrophils and lymphocytes, at inflammatory sites but can also cause tissue pathologies. Conversely, certain Th17 cells can also negatively regulate immune responses by secreting immunosuppressive factors, such as IL-10; these cells are termed non-pathogenic Th17 cells. In this review, we summarize recent advances in the development and regulatory functions of non-pathogenic Th17 cells in autoimmune diseases.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Targeting Th17 cells in autoimmune diseases
    Yang, Jianfei
    Sundrud, Mark S.
    Skepner, Jill
    Yamagata, Tetsuya
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (10) : 493 - 500
  • [12] Th17 Cells in Autoimmune and Infectious Diseases
    Francisco Zambrano-Zaragoza, Jose
    Jhonatan Romo-Martinez, Enrique
    de Jesus Duran-Avelar, Ma
    Garcia-Magallanes, Noemi
    Vibanco-Perez, Norberto
    INTERNATIONAL JOURNAL OF INFLAMMATION, 2014, 2014
  • [13] The pathogenicity of Th17 cells in autoimmune diseases
    Keiko Yasuda
    Yusuke Takeuchi
    Keiji Hirota
    Seminars in Immunopathology, 2019, 41 : 283 - 297
  • [14] Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis
    Tseveleki, Vivian
    Tselios, Theodore
    Kanistras, Ioannis
    Koutsoni, Olga
    Karamita, Maria
    Vamvakas, Sotiris-Spyros
    Apostolopoulos, Vasso
    Dotsika, Eleni
    Matsoukas, John
    Lassmann, Hans
    Probert, Lesley
    EXPERIMENTAL NEUROLOGY, 2015, 267 : 254 - 267
  • [15] Plasticity of Th17 Cells in Autoimmune Kidney Diseases
    Krebs, Christian F.
    Turner, Jan-Eric
    Paust, Hans-Joachim
    Kapffer, Sonja
    Koyro, Tobias
    Krohn, Sonja
    Ufer, Friederike
    Friese, Manuel A.
    Flavell, Richard A.
    Stockinger, Brigitta
    Steinmetz, Oliver M.
    Stahl, Rolf A. K.
    Huber, Samuel
    Panzer, Ulf
    JOURNAL OF IMMUNOLOGY, 2016, 197 (02): : 449 - 457
  • [16] Role of Th17 cells in infectious and autoimmune diseases
    Cambier, L.
    Defaweux, V
    Baldo, A.
    Mathy, A.
    Tabart, J.
    Bagut, E. T.
    Antoine, N.
    Mignon, B.
    ANNALES DE MEDECINE VETERINAIRE, 2010, 154 (02) : 104 - 112
  • [17] Dysregulation of Th17 and Treg cells in autoimmune diseases
    Astier, Anne L.
    Kofler, David M.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [18] Autoimmune diseases in the TH17 era
    Mesquita, D., Jr.
    Cruvinel, W. M.
    Camara, N. O. S.
    Kallas, E. G.
    Andrade, L. E. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (06) : 476 - 486
  • [19] Th17 Response and Inflammatory Autoimmune Diseases
    Waite, Janelle C.
    Skokos, Dimitris
    INTERNATIONAL JOURNAL OF INFLAMMATION, 2012, 2012
  • [20] Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms
    Wang, Yi
    Fang, Sijie
    Zhou, Huifang
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (02)